North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, PHM CRM, RCM, Telehealth, Healthcare Analytics, Supply Chain Management, mHealth, Fraud Analytics, Medication & Claims Management) End User (Provider,Payer) – Forecast to 2025

2020-01-10
Price :
Published : Jan-2020
No. of Pages : 274

“North America healthcare IT market size to grow at a 16.4% CAGR”

The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4%. There is a growing inclination across the globe towards the adoption of healthcare technologies due to the increasing need to deliver quality care to patients while curtailing escalating costs. These robust IT solutions are designed to streamline workflow in healthcare systems, reduce expenses, and facilitate compliance with stringent regulatory guidelines.

“Based on products and services, the healthcare providers segment accounted for the largest share of the North America Healthcare IT market in 2018”

Based on products and services, the market is segmented into healthcare provider solutions, healthcare payer solutions, and HCIT outsourcing services. In 2019, the healthcare providers segment accounted for the largest share of the North America healthcare IT industry. The need to control the increasing healthcare costs and improve the efficiency of services by reducing medical errors are the major drivers that are propelling the demand for healthcare provider solutions.

“By components, the services segment accounted for the largest market share in 2018”

Based on components, the North America healthcare IT market is segmented into services, software, and hardware. The services segment accounted for the largest market share in 2018.This is due to the introduction of complex software, the need for integration and interoperability of software, and the growing demand for consulting and outsourcing of various healthcare processes such as revenue cycle management, EHR management, and fraud detection.

”By end user, the healthcare providers segment accounted for the largest share of the North America Healthcare IT market in 2018”

Based on end-users, the market is segmented into healthcare providers and healthcare payers. In 2018, the healthcare providers segment accounted for the largest share of the North America healthcare IT industry. This is attributed to government initiatives to improve the quality of patient care and the need to control growing healthcare costs & improve the efficiency of healthcare services.

Breakdown of primary participants is as mentioned below:

  • By Company Type: Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
  • By Designation: C-level: 40%, Director-level: 35%, and Others: 25%
  • By Region: US: 75%, Canada: 20%, Mexico: 5%

Prominent players in the North America healthcare IT market are Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), Change Healthcare (US), Optum (US), McKesson Corporation (US), Oracle Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Athena health, Inc. (US), Infor, Inc. (US), Cognizant (US), Dell Technologies (US), and CVS Health (US).

Research Coverage:

The report analyzes the North America healthcare IT market and aims at estimating the current size and future growth potential based on various segments, such as products & services, components, end-users, and region. It also covers competitive leadership mapping, which helps in analyzing the position of key market companies as visionary leaders, innovators, dynamic players, and emerging players. The report also provides a competitive analysis of the leading players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the North America healthcare IT market. The report analyzes this market by products and services, components, end-users, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the North America healthcare IT industry.
  • Market Development: Comprehensive information on the lucrative emerging markets by products and services, components, end-users, and region.
  • Market Diversification: Exhaustive information about new testing services, recent developments, and investments in the North America healthcare IT industry.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, and capabilities of leading players in the North America healthcare IT market.
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024

“Growing incidence of chronic health conditions among women and the demand in contraceptives to prevent unintended pregnancies are the key factors driving the women’s healthcare market.” The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period. Growth in this market is mainly driven by the growing incidence of chronic health conditions among women, growing demand for contraceptives to prevent unintended pregnancies, growing focus on R&D by key players for the development of advanced products, and the government initiatives to curb population growth. On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth. “Prolia is the larg......
$5650

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024

“The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019–2024).” The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. “By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.” Based on component, the stable isotope-labe......
$5650

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house ......
$1995

Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2028

Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 Summary MS is a primary autoimmune disease with a mechanism involving recurrent inflammatory attacks on the central nervous system (CNS) due to a dysfunctional immune system, leading to neurological disability . The exact underlying cause of the inflammatory autoimmune process remains unknown; however, it is widely believed that MS results from a complex interaction of genetic susceptibility and environmental factors. MS is primarily considered an inflammatory demyelinating disorder of the CNS, and is characterized by lymphocyte and macrophage infiltrates, as well as glial cell activation. The key pathological finding in MS neural tissue is the presence of diffuse inflammatory lesions, also known as plaques, which are......
$10995

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028 Summary Seasonal influenza is a contagious respiratory viral illness. There are four types of seasonal influenza viruses (A, B, C, and D); however, only types A and B cause human disease of public health concern. Influenza transmission occurs when people with flu cough, sneeze, or talk and disseminate droplets. These droplets can land in the mouths or noses of people who then inhale them into the lungs. GlobalData epidemiologists identified country-specific population-based studies published in peer-reviewed journal articles and government-collated surveillance data to build the influenza forecast, and utilized appropriate proxy data where applicable. In 2018, there were 18,518,017 cases of lab-confirmed seasonal ......
$3495

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and i......
$1995

Generalized Seizures Global Clinical Trials Review, H2, 2019

Generalized Seizures Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2019" provides an overview of Generalized Seizures clinical trials scenario. This report provides top line data relating to the clinical trials on Generalized Seizures . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clini......
$2500

Myocardial Ischemia Global Clinical Trials Review, H2, 2019

Myocardial Ischemia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2019" provides an overview of Myocardial Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Myocardial Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Treatment Resistant Depression Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's pro......
$2500

Oral Mucositis Global Clinical Trials Review, H2, 2019

Oral Mucositis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Oral Mucositis Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Oral Mucositis clinical trials scenario. This report provides top line data relating to the clinical trials on Oral Mucositis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials data......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy